{"gene":"TGM2","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2006,"finding":"GPR56 binds specifically to tissue transglutaminase TG2 in the extracellular matrix, and this interaction suppresses melanoma tumor growth and metastasis; GPR56 associates in a complex with Gαq and the tetraspanin CD81.","method":"Co-immunoprecipitation, binding assays, overexpression/knockdown experiments, xenograft tumor models","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding demonstrated, functional consequence (tumor suppression) confirmed in vivo, independently followed up by multiple subsequent studies","pmids":["16757564"],"is_preprint":false},{"year":2013,"finding":"GPR56 antagonizes TG2 function in melanoma by internalizing and degrading extracellular TG2, leading to decreased fibronectin deposition and impaired focal adhesion kinase accumulation; TG2 crosslinking activity promotes melanoma growth.","method":"Xenograft studies in immunodeficient Tg2-/- mice, cell-based internalization/degradation assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic model (Tg2-/- mice), mechanistic pathway (ECM deposition/FAK) established, replicates and extends earlier GPR56-TG2 finding","pmids":["24356421"],"is_preprint":false},{"year":2006,"finding":"TG2 associates with β1 and β5 integrins on the surface of drug-resistant MCF-7 breast cancer cells, and this interaction strongly activates focal adhesion kinase, promoting fibronectin-mediated cell attachment and survival; siRNA knockdown of TG2 inhibits these functions.","method":"Co-immunoprecipitation, siRNA knockdown, fibronectin attachment assays, FAK activation assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP of TG2-integrin complex, functional siRNA rescue, multiple orthogonal methods in single lab","pmids":["16449978"],"is_preprint":false},{"year":2009,"finding":"Increased TG2 expression in fibroblasts activates NF-κB, resulting in upregulation of TGFβ1 expression and secretion of biologically active TGFβ1, leading to increased collagen and fibronectin synthesis and deposition; this process requires TG2 transamidase activity and can be inhibited by nitric oxide (via S-nitroso-N-acetylpenicillamine), which reduces TG2 activity and arrests the inactive enzyme on the cell surface.","method":"Tetracycline-inducible TG2 expression in Swiss 3T3 fibroblasts, site-directed TG inhibitor, NF-κB reporter assay, NO donor treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — inducible expression system with site-directed inhibitor controls, NF-κB reporter, multiple orthogonal endpoints in one study","pmids":["19657147"],"is_preprint":false},{"year":2011,"finding":"TG2 transamidating activity is the primary biochemical function required for both apoptosis protection and autophagosome formation; TG2 knockout MEF cells show exacerbated caspase-3 and PARP cleavage upon apoptotic stimuli and accumulation of LC3-II upon autophagy induction, whereas reconstitution with wild-type TG2 but not the transamidation-inactive C277S mutant rescues both phenotypes.","method":"TG2 knockout MEF reconstitution with WT or C277S mutant TG2, caspase-3 activity assays, PARP cleavage, LC3-II immunoblotting","journal":"Amino acids","confidence":"High","confidence_rationale":"Tier 1 / Moderate — active-site mutagenesis (C277S) plus knockout reconstitution with defined molecular readouts, multiple orthogonal methods","pmids":["21479826"],"is_preprint":false},{"year":2005,"finding":"TG2 acting as a G protein mediates intracellular signaling via the α1b-adrenergic receptor in hepatocytes, and this signaling regulates Bcl-xL expression; TG2-/- mice show increased hepatocyte sensitivity to Fas-mediated apoptosis with decreased Bcl-xL levels, while Fas receptor levels, FLIP(L), and IκBα degradation are unchanged.","method":"TG2 knockout mice, anti-Fas antibody challenge (in vivo and in vitro), Bcl-xL/FLIP(L) immunoblotting, cell-surface Fas quantification","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo genetic KO model with specific mechanistic readout (Bcl-xL via adrenergic signaling), multiple molecular controls in one study","pmids":["16108039"],"is_preprint":false},{"year":2013,"finding":"TG2 directly interacts with S100A4 and crosslinks it (polymerizes it); S100A4 is a TG2 substrate. Inhibition of TG2 (by inhibitors or shRNA) blocks S100A4-accelerated mammary tumor cell migration. The signaling mechanism involves syndecan-4 and α5β1 integrin co-signaling linked by PKCα activation.","method":"Co-immunoprecipitation, Far Western blotting, crosslinking assays, TG2 inhibitors (cell-permeable and non-cell-permeable), shRNA knockdown, functional blocking antibodies","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro enzymatic crosslinking assay confirming substrate relationship, reciprocal co-IP, multiple inhibitor strategies with migration readout","pmids":["23469180"],"is_preprint":false},{"year":2012,"finding":"PKA-induced phosphorylation of TG2 at serine-216 is required for TG2-mediated activation of NF-κB, Akt phosphorylation, and downregulation of PTEN; a mutant TG2 lacking Ser216 (m-TG2) fails to activate NF-κB and Akt, and fails to suppress PTEN, indicating this PTM controls TG2's pro-survival signaling.","method":"TG2-null MEF reconstitution with WT or Ser216A mutant TG2, NF-κB reporter assay, immunoblotting, FACS, cell migration assay; confirmed in MCF-7 and T-47D breast cancer cells","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis of phosphorylation site, NF-κB reporter, replicated in two cell lines; single lab","pmids":["22759359"],"is_preprint":false},{"year":2018,"finding":"TG2, dependent on its protein disulfide isomerase (PDI) activity, triggers trimerization and nuclear translocation of HSF1, activating the heat-shock response; loss of TG2 correlates with defective HSF1 nuclear translocation and reduced binding to the HSP70 promoter. TG2 absence impairs the HSF1-HSP70 pathway in cystic fibrosis cells and increases CFTR function by ~40% in TG2-/- CF mouse models.","method":"TG2 knockout mice (CF model), TG2 loss-of-function in cells, HSF1 DNA-binding/promoter assay, nuclear translocation imaging, CFTR functional measurement","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo KO model, multiple orthogonal methods (nuclear translocation, DNA binding, functional CFTR assay), mechanistic activity (PDI) identified","pmids":["29752334"],"is_preprint":false},{"year":2022,"finding":"TGM2-mediated histone serotonylation (monoaminylation of H3Q5) is excluded from constitutive heterochromatic regions because higher-order chromatin structure imposes a steric barrier; nucleosome-level studies show steric hindrance restricts TGM2 activity to accessible histone tail sites, with substrate accessibility—not primary sequence or pre-existing PTMs—being the primary determinant of TGM2-mediated histone monoaminylation.","method":"Biochemical histone serotonylation assays with chromatin substrates, DNA-barcoded nucleosome libraries, structure-activity relationship studies, mammalian cell chromatin mapping","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with nucleosome libraries, multiple orthogonal biochemical and cell-based approaches, mechanistic principle established","pmids":["36256821"],"is_preprint":false},{"year":2020,"finding":"TGM2 promotes formation of mitochondria-associated ER membranes (MAMs) and facilitates IP3R1–VDAC1 interactions, resulting in mitochondrial calcium influx and mtROS accumulation; TGM2 silencing inhibits IP3R1–VDAC1 tethering and prevents high glucose-induced mitochondrial calcium overload.","method":"TGM2 siRNA knockdown, co-immunoprecipitation of IP3R1-VDAC1, mitochondrial calcium measurement (Fluo-4AM), mtROS assay, STZ-induced diabetic mouse model","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP demonstrating tethering complex, siRNA loss-of-function with calcium/ROS readouts, in vivo STZ model; single lab","pmids":["32704090"],"is_preprint":false},{"year":2022,"finding":"After irradiation, TGM2 binds SDC1 and is transported from the cell membrane to lysosomes; TGM2 then binds LC3 through two LC3-interacting regions (LIRs), coordinating autophagosome-lysosome fusion by enabling lysosomal EPG5 to recognize LC3 and stabilize the STX17-SNAP29-VAMP8 SNARE complex assembly, thereby promoting radioresistance in glioblastoma.","method":"Co-immunoprecipitation, confocal imaging of autophagosome-lysosome fusion, mRFP-GFP-LC3 reporter, LIR mutation analysis, TGM2 inhibitor (cystamine) in orthotopic GBM mice","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP defining multi-protein complex, LIR-LC3 interaction, mechanistic pathway through SNARE complex, in vivo model with survival endpoint","pmids":["35913916"],"is_preprint":false},{"year":2023,"finding":"After irradiation, SDC1 carries TGM2 from the cell membrane into cytoplasm and transports it to lysosomes via flotillin 1 (FLOT1); TGM2 then recognizes BHMT on autophagosomes to coordinate autophagosome-lysosome encounter, forming the SDC1-TGM2-FLOT1-BHMT complex that maintains autophagic flux and enhances GBM radioresistance.","method":"Co-immunoprecipitation, TMT quantitative proteomics, immunofluorescence, mRFP-GFP-LC3, transmission electron microscopy, colony formation assays","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP defining four-protein complex, multiple imaging methods; single lab, partially overlapping with prior study (PMID 35913916)","pmids":["37441590"],"is_preprint":false},{"year":2022,"finding":"Cytosolic TGM2 suppresses TRIM21-mediated ubiquitination and degradation of STAT1 by facilitating dissociation of the TRIM21–STAT1 complex; this requires TGM2's GTP-binding enzymatic activity (not transamidase activity), stabilizing STAT1 and promoting gastric cancer progression. TRIM21 is identified as the E3 ubiquitin ligase for STAT1 in gastric cancer.","method":"Co-immunoprecipitation, mass spectrometry, TGM2 GTP-binding mutants, calcium ionophore (A23187) to abolish GTP-binding activity, ubiquitination assays, xenograft models","journal":"Cancer communications (London, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — MS-identified interactors, enzymatic activity mutants distinguishing GTP-binding vs transamidase, ubiquitination assay, in vivo rescue; single lab","pmids":["36353796"],"is_preprint":false},{"year":2016,"finding":"TG2 forms complexes with NF-κB components and induces IL-6 production, which in turn triggers enhanced autophagy in drug-resistant mantle cell lymphoma cells through STAT3 signaling; ATG5 positively feeds back to regulate TG2/NF-κB/IL-6 signaling, constituting a positive feedback loop for MCL cell survival.","method":"CRISPR-mediated TG2 silencing, TG2 overexpression, co-immunoprecipitation with NF-κB components, autophagy assays, IL-6 measurements, xenograft models","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO, co-IP, multiple functional readouts; single lab","pmids":["27488529"],"is_preprint":false},{"year":2010,"finding":"Active TG2 directly interacts with β3 integrins (demonstrated by co-immunoprecipitation), acting as a co-receptor for fibronectin; active TG2 (but not the C277S transamidation-inactive mutant) increases TGFβ1 levels and matrix-deposited fibronectin in CT26 colon carcinoma cells, increasing cell adhesion and reducing migration/invasion.","method":"Stable transfection of WT vs. C277S TG2 mutant in CT26 cells, immunoprecipitation of TG2-β3 integrin complex, TG2 site-directed inhibitors, TGFβ1 ELISA, fibronectin deposition assays","journal":"Amino acids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus active-site mutant comparison, multiple functional readouts; single lab","pmids":["21046178"],"is_preprint":false},{"year":2015,"finding":"Inhibition of TG2 transamidase activity with a cell-permeable fluorescent peptidomimetic inhibitor blocks TG2 binding to cell surface syndecan-4, inhibits translocation of TG2 into the ECM, and reduces fibronectin deposition, cell motility, and cord formation; in a mouse model of hypertensive nephrosclerosis, TG2 inhibition reduced collagen deposition by >40%.","method":"Fluorescently labeled cell-permeable TG2 inhibitor, live-cell imaging, fibronectin deposition assays, Matrigel cord assay, hypertensive nephrosclerosis mouse model","journal":"Chemistry & biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific inhibitor with multiple orthogonal cellular and in vivo readouts; single lab","pmids":["26456735"],"is_preprint":false},{"year":2007,"finding":"Missense mutations in TGM2 located near the catalytic site (N333S, M330R, I331N) impair transamidating activity in vitro; TG2 is the only transglutaminase significantly expressed in human pancreatic islet cells, and Tgm2-/- mice are glucose-intolerant with impaired insulin secretion.","method":"In vitro transamidation activity assay of mutant TG2 proteins, gene expression analysis in human pancreas, Tgm2 knockout mouse phenotyping (glucose tolerance test)","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro enzymatic assay of patient-derived mutants, KO mouse phenotype; single lab","pmids":["17939176"],"is_preprint":false},{"year":2020,"finding":"Hypoxia enhances TG2 expression and activity in pulmonary vein smooth muscle cells (hPVSMC) in a HIF-2-dependent manner; TG2 mediates serotonylation (covalent serotonin modification) of SERCA2, inhibiting SERCA2 activity and increasing cytosolic calcium via TRPC6-mediated calcium influx; vascular smooth muscle-specific Tgm2-/- mice are protected from hypoxia-induced pulmonary hypertension.","method":"Co-immunoprecipitation of TG2 and SERCA2, TG2 gene silencing/overexpression, calcium imaging (Fluo-4AM), smooth muscle-specific TG2 knockout mice, hypoxic pulmonary hypertension model (RVSP, RVHI measurements)","journal":"Frontiers in pharmacology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro enzymatic serotonylation assay (co-IP), tissue-specific KO mouse with disease phenotype, multiple mechanistic readouts","pmids":["32116663"],"is_preprint":false},{"year":2022,"finding":"Lung-resident neutrophils express TGM2, which is induced by PGE2 via protein kinase A (PKA) signaling; TGM2 mediates the immune-suppressive phenotype of lung neutrophils, and Tgm2-/- mice release high levels of inflammatory cytokines and show exacerbated lung damage in LPS-induced acute respiratory distress syndrome.","method":"Tgm2-/- mice, LPS-induced ARDS model, bronchoalveolar lavage fluid treatment of bone marrow neutrophils, PGE2/PKA pathway pharmacological dissection","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO model with defined disease phenotype and pathway (PGE2/PKA/TGM2) established; single lab","pmids":["35679477"],"is_preprint":false},{"year":2010,"finding":"TG2 overexpression in neuroblastoma SH-SY5Y cells protects against etoposide-induced cell death; this protection requires transamidase activity since the C277S inactive mutant fails to suppress caspase-3 activation and p53 phosphorylation.","method":"Overexpression of WT vs. C277S TG2 mutant, antisense TG2 knockdown, caspase-3 activity assay, p53 phosphorylation immunoblotting","journal":"Amino acids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — active-site mutagenesis distinguishing transamidase activity, loss-of-function antisense construct, defined molecular readouts; single lab","pmids":["20112034"],"is_preprint":false},{"year":2016,"finding":"PARP3 promotes TGFβ-induced EMT by stimulating a TG2-Snail-E-cadherin axis; PARP3 depletion prevents TGFβ-dependent induction of TG2 and Snail expression, dissolution of cell junctions, and acquisition of cell motility.","method":"PARP3 siRNA depletion, TGFβ stimulation, immunoblotting for TG2/Snail/E-cadherin, cell motility assays, mammary epithelial and breast cancer cell models","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA depletion with defined axis (TG2-Snail-E-cadherin), multiple cell types tested; single lab, no direct TG2-PARP3 binding shown","pmids":["27579892"],"is_preprint":false},{"year":2022,"finding":"Weakly migratory metastatic breast cancer cells release microvesicles rich in TG2, which activate murine fibroblasts and lead weakly migratory cancer cell migration in vitro; these microvesicles induce tumor stiffening and fibroblast activation in vivo and enhance metastasis of weakly migratory cells.","method":"Microvesicle isolation, TG2 content analysis, fibroblast activation assays, in vitro migration, in vivo tumor stiffness and metastasis models","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — TG2 identified as active cargo in microvesicles, in vitro and in vivo functional validation; single lab","pmids":["36475545"],"is_preprint":false},{"year":2023,"finding":"Fyn tyrosine kinase phosphorylates TGM2 on tyrosine-369 (Y369); Fyn-dependent phosphorylation of TGM2 regulates autophagy in proximal renal tubules, and TGM2 knockdown decreases p53 expression in autophagic conditions, identifying a Fyn-TGM2-p53 axis in diabetic kidney disease.","method":"Phospho-proteomic analysis, in vitro kinase assay, TGM2 knockdown in proximal tubule cells, STZ-induced hyperglycemic mouse model, immunoblotting","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — phospho-proteomics identifying Y369 site, in vitro and in vivo validation; single lab","pmids":["37190106"],"is_preprint":false},{"year":2025,"finding":"TGM2 catalyzes H3Q5 serotonylation (H3Q5ser) in hepatocellular carcinoma; transcriptional intermediary factor 1β (TIF1β) mediates recruitment of TGM2 to MYC target gene loci, facilitating H3Q5ser modifications that promote MYC pathway gene expression and HCC progression.","method":"CUT&Tag (chromatin profiling), RNA sequencing, adeno-associated virus liver-specific TGM2/H3.3 overexpression, HCC organoids, xenograft and hydrodynamic tail vein injection models, TGM2 inhibitor treatment","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — CUT&Tag chromatin mapping, multiple in vivo models, specific enzymatic activity (transglutaminase) validated, TIF1β-TGM2 recruitment mechanism identified","pmids":["39788430"],"is_preprint":false},{"year":2016,"finding":"In microglia, TGM2's proinflammatory effects are dependent on its GTP-binding activity rather than transamidase activity; TGM2 activates the NF-κB signaling pathway to facilitate microglial activation, and propofol inhibits microglial inflammation by suppressing TGM2 expression and downstream NF-κB signaling.","method":"TGM2 siRNA knockdown, gain-of-function overexpression with GTP-binding vs. transamidase activity mutants, NF-κB signaling assays, BV2 cells and primary microglia","journal":"Journal of immunology research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — activity-specific mutants distinguishing GTP-binding from transamidase function, loss- and gain-of-function in two cell types; single lab","pmids":["34485533"],"is_preprint":false},{"year":2024,"finding":"RSL3-induced oxidative stress promotes S-glutathionylation of TGM2 via upregulation of GSTP1, leading to proteasomal degradation of TGM2; this suppresses nuclear accumulation of TGM2 and disrupts TGM2–topoisomerase IIα interaction after irradiation, impairing DNA DSB repair and sensitizing glioma cells to radiation.","method":"TGM2 overexpression/knockdown, co-immunoprecipitation of TGM2-topoisomerase IIα, S-glutathionylation detection, γH2AX DSB assay, GSTP1 manipulation, U87 xenograft model","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP identifying TGM2-topoisomerase IIα interaction, PTM (S-glutathionylation) identified with functional consequence, in vivo xenograft; single lab","pmids":["39580966"],"is_preprint":false},{"year":2013,"finding":"TG2 inhibition (by site-directed irreversible inhibitors or antisense transfection) blocks tubular structure formation in a vasculogenic mimicry model; TG2 in situ activity co-localizes with fibronectin and collagen IV in tube structures, and non-cell-permeable TG inhibitors reduce ECM deposition, indicating TG2's contribution to tube formation is extracellular.","method":"TG2 antisense transfection, cell-permeable and non-cell-permeable TG2 site-directed inhibitors, in situ TG activity assay, co-localization with fibronectin/collagen IV, tube formation assay","journal":"Amino acids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-permeable vs non-cell-permeable inhibitor strategy distinguishes intracellular vs extracellular TG2 activity, antisense KD; single lab","pmids":["22231926"],"is_preprint":false},{"year":2017,"finding":"TG2 and FXIII-A control monocyte-macrophage differentiation into osteoclasts and regulate RANKL production in mesenchymal stem cells and adipocytes; TG2/FXIII-A-deficient mice show increased osteoclastogenesis and trabecular bone loss, while TG2/FXIII-A-null MSCs show defective plasma fibronectin assembly.","method":"TG2 and FXIII-A double-knockout mice, in vitro osteoclastogenesis assays, chemical TG activity inhibition, bone histomorphometry, FN assembly assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO model with bone phenotype, in vitro cellular differentiation assays, chemical inhibitor to distinguish TG isoforms; single lab","pmids":["28387755"],"is_preprint":false},{"year":2020,"finding":"AFF1 binds directly to the promoter region of the Tgm2 gene and regulates its transcription; AFF1 depletion enhances adipogenic differentiation of hMSCs, and overexpression of TGM2 largely rescues adipogenic differentiation in AFF1-deficient cells, placing TGM2 downstream of AFF1 in adipogenesis.","method":"ChIP-qPCR demonstrating AFF1 binding to TGM2 promoter, AFF1 siRNA and overexpression, TGM2 overexpression rescue, oil red O staining, in vivo adipose formation assay","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-qPCR directly demonstrating promoter binding, rescue experiment with TGM2 overexpression; single lab","pmids":["32441391"],"is_preprint":false},{"year":2016,"finding":"TG2 activity is increased in mast cells activated via IgE; serum TG2 activity is elevated in CSU patients and positively correlates with inflammatory mediator levels (histamine, LTC4, TNF-α, TGF-β, IL-4, IL-5, IL-6), and TG2 co-localizes with the mast cell marker c-kit in CSU lesional skin.","method":"Serum TG2 ELISA activity assay, IgE-activated CBMC and PBMC-derived mast cells, immunofluorescence co-localization in skin biopsies","journal":"Annals of allergy, asthma & immunology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative serum activity data plus single immunofluorescence co-localization; no direct mechanistic link established","pmids":["27613463"],"is_preprint":false}],"current_model":"TGM2 (tissue transglutaminase 2) is a multifunctional Ca²⁺-dependent enzyme with transamidase (protein crosslinking), GTPase/G-protein signaling, protein disulfide isomerase, and kinase activities; its transamidase activity crosslinks ECM proteins (fibronectin, collagen), serotonylates substrates (SERCA2, histone H3Q5), and regulates apoptosis and autophagy, while its GTP-binding activity mediates adrenergic receptor signaling, NF-κB activation, and STAT1 stabilization; at the cell surface it forms co-receptor complexes with β1/β3/β5 integrins and syndecan-4 to activate FAK and PKCα-mediated adhesion/survival signaling, is regulated by phosphorylation (Ser216 by PKA; Tyr369 by Fyn) and S-glutathionylation, and is inhibited extracellularly by GPR56-mediated internalization and degradation; within the nucleus TGM2 installs H3Q5 serotonylation at MYC target genes via TIF1β recruitment to promote transcription, and its PDI activity activates HSF1 trimerization to drive the heat-shock response."},"narrative":{"mechanistic_narrative":"TGM2 is a multifunctional enzyme whose distinct biochemical activities—Ca²⁺-dependent transamidation, GTP-binding, and protein disulfide isomerase (PDI) activity—drive context-specific control of extracellular matrix assembly, cell survival, autophagy, and transcription [PMID:21479826, PMID:29752334, PMID:36353796]. Its transamidase activity, dependent on the active-site cysteine (mutated in C277S), is the primary function required for protection from apoptosis and for autophagosome formation, crosslinks matrix proteins, and polymerizes substrates such as S100A4 to promote tumor cell migration [PMID:21479826, PMID:23469180, PMID:20112034]. At the cell surface TGM2 acts as a fibronectin co-receptor in complexes with β1/β3/β5 integrins and syndecan-4, activating focal adhesion kinase and PKCα to drive fibronectin-mediated adhesion and survival signaling [PMID:16449978, PMID:23469180, PMID:21046178], and it promotes a feed-forward fibrotic program by activating NF-κB to upregulate TGFβ1 and increase collagen/fibronectin deposition [PMID:19657147, PMID:26456735]. Through monoaminylation chemistry TGM2 serotonylates SERCA2 to inhibit calcium reuptake in hypoxic pulmonary smooth muscle and installs H3Q5 serotonylation on chromatin, with substrate accessibility rather than sequence determining nucleosomal targeting, and TIF1β recruiting TGM2 to MYC target loci to activate transcription [PMID:36256821, PMID:32116663, PMID:39788430]. Independently of transamidation, TGM2's GTP-binding activity activates NF-κB and stabilizes STAT1 by displacing it from the TRIM21 E3 ligase, while its PDI activity triggers HSF1 trimerization and the heat-shock response [PMID:29752334, PMID:36353796, PMID:34485533]. TGM2 activity and localization are tuned by post-translational modifications—PKA phosphorylation at Ser216 enables NF-κB/Akt pro-survival signaling, Fyn phosphorylation at Tyr369 regulates autophagy, and S-glutathionylation triggers its degradation [PMID:22759359, PMID:37190106, PMID:39580966]. Genetically, TGM2 catalytic-site missense mutations impair transamidation and Tgm2-deficient mice are glucose-intolerant with impaired insulin secretion, linking the enzyme to islet function [PMID:17939176].","teleology":[{"year":2005,"claim":"Established that TGM2 functions as a G protein in receptor signaling distinct from its crosslinking role, controlling apoptotic threshold via Bcl-xL.","evidence":"Tgm2 knockout mice challenged with anti-Fas, with Bcl-xL/FLIP immunoblotting and α1b-adrenergic receptor analysis in hepatocytes","pmids":["16108039"],"confidence":"High","gaps":["Did not resolve which TGM2 enzymatic activity (GTP-binding vs transamidase) mediates the adrenergic signaling","Mechanism of Bcl-xL transcriptional control left undefined"]},{"year":2006,"claim":"Defined TGM2's cell-surface role as an integrin co-receptor that activates FAK to drive fibronectin adhesion and survival, and identified GPR56 as a binding partner that suppresses tumor growth.","evidence":"Co-IP of TG2–integrin and TG2–GPR56 complexes, siRNA knockdown, fibronectin attachment/FAK assays, xenograft models","pmids":["16449978","16757564"],"confidence":"High","gaps":["Whether integrin binding requires catalytic activity not addressed","Structural basis of TG2–GPR56 interaction unknown"]},{"year":2009,"claim":"Showed that TGM2 transamidase activity drives a profibrotic program by activating NF-κB and inducing TGFβ1, connecting the enzyme to matrix synthesis.","evidence":"Tetracycline-inducible TG2 in fibroblasts, site-directed TG inhibitor, NF-κB reporter, NO donor treatment","pmids":["19657147"],"confidence":"High","gaps":["Direct crosslinking substrate triggering NF-κB not identified","How NO arrests enzyme on cell surface mechanistically unclear"]},{"year":2010,"claim":"Used active-site mutants to prove transamidase activity is required for TGM2's anti-apoptotic function and to confirm β3-integrin co-receptor activity raises matrix fibronectin.","evidence":"WT vs C277S TG2 in neuroblastoma and colon carcinoma cells, caspase-3/p53 assays, TG2–β3 co-IP, fibronectin deposition","pmids":["20112034","21046178"],"confidence":"Medium","gaps":["Survival substrate of transamidation not identified","Single-lab findings for each cell context"]},{"year":2011,"claim":"Pinpointed transamidation as the single activity required for both apoptosis protection and autophagosome formation using knockout reconstitution.","evidence":"TG2-null MEF reconstituted with WT or C277S, caspase-3/PARP cleavage and LC3-II immunoblotting","pmids":["21479826"],"confidence":"High","gaps":["Molecular crosslinking targets governing autophagy unresolved","Subcellular site of relevant activity not localized"]},{"year":2012,"claim":"Identified PKA-mediated Ser216 phosphorylation as a switch enabling TGM2's pro-survival NF-κB/Akt/PTEN signaling.","evidence":"TG2-null MEF reconstituted with WT or Ser216A mutant, NF-κB reporter, immunoblotting, validated in two breast cancer lines","pmids":["22759359"],"confidence":"Medium","gaps":["Whether Ser216 phosphorylation alters enzymatic activity unclear","Single lab"]},{"year":2013,"claim":"Established that TGM2 polymerizes S100A4 to promote migration, that the GPR56 antagonism proceeds via TG2 internalization/degradation, and that extracellular TG2 activity supports vasculogenic tube formation.","evidence":"Crosslinking/Far-Western/co-IP for S100A4, Tg2-/- xenografts for GPR56, cell-permeable vs non-permeable inhibitors for tube formation","pmids":["23469180","24356421","22231926"],"confidence":"High","gaps":["Syndecan-4/PKCα signaling steps downstream of S100A4 incompletely mapped","Identity of physiological extracellular substrates in tubes partial"]},{"year":2016,"claim":"Distinguished GTP-binding from transamidase activity in inflammatory signaling and embedded TGM2 in NF-κB/IL-6/autophagy survival loops and TGFβ-driven EMT axes.","evidence":"Activity-specific mutants in microglia, CRISPR silencing/co-IP with NF-κB in lymphoma, PARP3 depletion in EMT models, syndecan-4-targeted inhibitor","pmids":["34485533","27488529","27579892","26456735"],"confidence":"Medium","gaps":["Direct TG2–PARP3 binding not shown","GTP-binding effector linking to NF-κB not defined"]},{"year":2018,"claim":"Assigned a PDI-dependent function to TGM2 in triggering HSF1 trimerization and the heat-shock response, with disease relevance in cystic fibrosis.","evidence":"TG2 knockout CF mice, HSF1 nuclear translocation/DNA-binding assays, CFTR functional measurement","pmids":["29752334"],"confidence":"High","gaps":["Direct disulfide substrate on HSF1 not identified","How PDI activity is regulated in cells unclear"]},{"year":2020,"claim":"Defined serotonylation as a TGM2 catalytic output controlling calcium handling, modifying SERCA2 in hypoxic pulmonary smooth muscle and tethering ER–mitochondria membranes for calcium influx.","evidence":"TG2–SERCA2 and IP3R1–VDAC1 co-IPs, calcium/mtROS imaging, smooth-muscle-specific Tgm2-/- and STZ diabetic mouse models","pmids":["32116663","32704090"],"confidence":"High","gaps":["Whether MAM tethering involves crosslinking of specific substrates unresolved","HIF-2 to TG2 transcriptional link mechanism partial"]},{"year":2022,"claim":"Revealed TGM2 GTP-binding stabilizes STAT1 by displacing TRIM21, defined SDC1-dependent lysosomal trafficking that couples TGM2 to autophagosome–lysosome fusion, and showed chromatin accessibility governs histone serotonylation.","evidence":"GTP-binding mutants/ubiquitination assays for STAT1, LIR-mutation and SNARE-complex analysis for SDC1-TGM2-LC3, DNA-barcoded nucleosome libraries for H3Q5ser, microvesicle TG2 cargo assays","pmids":["36353796","35913916","36256821","35679477","36475545"],"confidence":"High","gaps":["How GTP-binding promotes TRIM21–STAT1 dissociation structurally unknown","Signal triggering SDC1-mediated TGM2 internalization beyond irradiation unclear"]},{"year":2023,"claim":"Mapped Fyn phosphorylation of TGM2 at Tyr369 regulating renal autophagy and extended the SDC1 trafficking complex to FLOT1 and BHMT for radioresistance.","evidence":"Phospho-proteomics/in vitro kinase assay for Y369, TMT proteomics and co-IP for SDC1-TGM2-FLOT1-BHMT complex, STZ and GBM models","pmids":["37190106","37441590"],"confidence":"Medium","gaps":["Functional consequence of Y369 phosphorylation on enzymatic activity not defined","Partly overlapping single-lab GBM studies"]},{"year":2024,"claim":"Showed S-glutathionylation, driven by GSTP1 under oxidative stress, degrades TGM2 and disrupts its nuclear topoisomerase IIα interaction, controlling DNA double-strand break repair.","evidence":"Co-IP of TGM2–topoisomerase IIα, S-glutathionylation detection, γH2AX assays, GSTP1 manipulation, U87 xenografts","pmids":["39580966"],"confidence":"Medium","gaps":["Whether TGM2 enzymatically modifies topoisomerase IIα unknown","Single lab"]},{"year":2025,"claim":"Established TGM2 as a chromatin-modifying enzyme recruited by TIF1β to MYC target loci to install H3Q5 serotonylation and activate oncogenic transcription.","evidence":"CUT&Tag, RNA-seq, AAV liver-specific overexpression, HCC organoids and in vivo models, TGM2 inhibitor","pmids":["39788430"],"confidence":"High","gaps":["How TIF1β selects specific MYC loci unresolved","Reader proteins for H3Q5ser not identified"]},{"year":null,"claim":"How TGM2's multiple activities (transamidase, GTP-binding, PDI) are coordinately switched within a single cell, and the rules governing its localization between surface, cytosol, mitochondria-associated membranes, and nucleus, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified structural model linking PTM state to activity selection","Trafficking determinants between compartments incompletely defined","Physiological serotonylation substrate repertoire largely uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4,6,18,24]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[13,25]},{"term_id":"GO:0016853","term_label":"isomerase activity","supporting_discovery_ids":[8]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[4,6,24]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[9,24]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[2,15]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,1,3,27]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,11,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[24,26]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[11,12]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[3,15,27]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[4,11,12,14]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,5,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,7,25]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[24,9]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[8]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[26]}],"complexes":["TGM2-integrin co-receptor complex","SDC1-TGM2-FLOT1-BHMT complex","GPR56-Gαq-CD81 complex"],"partners":["ITGB3","ITGB1","SDC4","SDC1","GPR56","S100A4","STAT1","MAP1LC3B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P21980","full_name":"Protein-glutamine gamma-glutamyltransferase 2","aliases":["Erythrocyte transglutaminase","Heart G alpha(h)","hhG alpha(h)","Isopeptidase TGM2","Protein G alpha(h)","G(h)","Protein-glutamine deamidase TGM2","Protein-glutamine dopaminyltransferase TGM2","Protein-glutamine histaminyltransferase TGM2","Protein-glutamine noradrenalinyltransferase TGM2","Protein-glutamine serotonyltransferase TGM2","Tissue transglutaminase","tTG","tTgase","Transglutaminase C","TG(C)","TGC","TGase C","Transglutaminase H","TGase H","Transglutaminase II","TGase II","Transglutaminase-2","TG2","TGase-2","hTG2"],"length_aa":687,"mass_kda":77.3,"function":"Calcium-dependent acyltransferase that catalyzes the formation of covalent bonds between peptide-bound glutamine and various primary amines, such as gamma-amino group of peptide-bound lysine, or mono- and polyamines, thereby producing cross-linked or aminated proteins, respectively (PubMed:23941696, PubMed:31991788, PubMed:9252372). Involved in many biological processes, such as bone development, angiogenesis, wound healing, cellular differentiation, chromatin modification and apoptosis (PubMed:1683874, PubMed:27270573, PubMed:28198360, PubMed:7935379, PubMed:9252372). Acts as a protein-glutamine gamma-glutamyltransferase by mediating the cross-linking of proteins, such as ACO2, HSPB6, FN1, HMGB1, RAP1GDS1, SLC25A4/ANT1, SPP1 and WDR54 (PubMed:23941696, PubMed:24349085, PubMed:29618516, PubMed:30458214). Under physiological conditions, the protein cross-linking activity is inhibited by GTP; inhibition is relieved by Ca(2+) in response to various stresses (PubMed:18092889, PubMed:7592956, PubMed:7649299). When secreted, catalyzes cross-linking of proteins of the extracellular matrix, such as FN1 and SPP1 resulting in the formation of scaffolds (PubMed:12506096). Plays a key role during apoptosis, both by (1) promoting the cross-linking of cytoskeletal proteins resulting in condensation of the cytoplasm, and by (2) mediating cross-linking proteins of the extracellular matrix, resulting in the irreversible formation of scaffolds that stabilize the integrity of the dying cells before their clearance by phagocytosis, thereby preventing the leakage of harmful intracellular components (PubMed:7935379, PubMed:9252372). In addition to protein cross-linking, can use different monoamine substrates to catalyze a vast array of protein post-translational modifications: mediates aminylation of serotonin, dopamine, noradrenaline or histamine into glutamine residues of target proteins to generate protein serotonylation, dopaminylation, noradrenalinylation or histaminylation, respectively (PubMed:23797785, PubMed:30867594). Mediates protein serotonylation of small GTPases during activation and aggregation of platelets, leading to constitutive activation of these GTPases (By similarity). Plays a key role in chromatin organization by mediating serotonylation and dopaminylation of histone H3 (PubMed:30867594, PubMed:32273471). Catalyzes serotonylation of 'Gln-5' of histone H3 (H3Q5ser) during serotonergic neuron differentiation, thereby facilitating transcription (PubMed:30867594). Acts as a mediator of neurotransmission-independent role of nuclear dopamine in ventral tegmental area (VTA) neurons: catalyzes dopaminylation of 'Gln-5' of histone H3 (H3Q5dop), thereby regulating relapse-related transcriptional plasticity in the reward system (PubMed:32273471). Regulates vein remodeling by mediating serotonylation and subsequent inactivation of ATP2A2/SERCA2 (By similarity). Also acts as a protein deamidase by mediating the side chain deamidation of specific glutamine residues of proteins to glutamate (PubMed:20547769, PubMed:9623982). Catalyzes specific deamidation of protein gliadin, a component of wheat gluten in the diet (PubMed:9623982). May also act as an isopeptidase cleaving the previously formed cross-links (PubMed:26250429, PubMed:27131890). Also able to participate in signaling pathways independently of its acyltransferase activity: acts as a signal transducer in alpha-1 adrenergic receptor-mediated stimulation of phospholipase C-delta (PLCD) activity and is required for coupling alpha-1 adrenergic agonists to the stimulation of phosphoinositide lipid metabolism (PubMed:8943303) Has cytotoxic activity: is able to induce apoptosis independently of its acyltransferase activity","subcellular_location":"Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P21980/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TGM2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TGM2","total_profiled":1310},"omim":[{"mim_id":"620826","title":"WD REPEAT-CONTAINING PROTEIN 54; WDR54","url":"https://www.omim.org/entry/620826"},{"mim_id":"613900","title":"TRANSGLUTAMINASE 6; TGM6","url":"https://www.omim.org/entry/613900"},{"mim_id":"609969","title":"SUPRABASIN","url":"https://www.omim.org/entry/609969"},{"mim_id":"604110","title":"ADHESION G PROTEIN-COUPLED RECEPTOR G1; ADGRG1","url":"https://www.omim.org/entry/604110"},{"mim_id":"603805","title":"TRANSGLUTAMINASE 5; TGM5","url":"https://www.omim.org/entry/603805"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"blood vessel","ntpm":775.7}],"url":"https://www.proteinatlas.org/search/TGM2"},"hgnc":{"alias_symbol":["TGC","TG2"],"prev_symbol":[]},"alphafold":{"accession":"P21980","domains":[{"cath_id":"2.60.40.10","chopping":"5-137","consensus_level":"high","plddt":94.0627,"start":5,"end":137},{"cath_id":"3.90.260.10","chopping":"158-458","consensus_level":"high","plddt":92.909,"start":158,"end":458},{"cath_id":"2.60.40.10","chopping":"472-582","consensus_level":"high","plddt":92.1609,"start":472,"end":582},{"cath_id":"2.60.40.10","chopping":"588-683","consensus_level":"high","plddt":95.3997,"start":588,"end":683}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21980","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21980-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21980-F1-predicted_aligned_error_v6.png","plddt_mean":92.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TGM2","jax_strain_url":"https://www.jax.org/strain/search?query=TGM2"},"sequence":{"accession":"P21980","fasta_url":"https://rest.uniprot.org/uniprotkb/P21980.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21980/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21980"}},"corpus_meta":[{"pmid":"16757564","id":"PMC_16757564","title":"GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16757564","citation_count":227,"is_preprint":false},{"pmid":"21902810","id":"PMC_21902810","title":"Extracellular TG2: emerging functions and regulation.","date":"2011","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/21902810","citation_count":164,"is_preprint":false},{"pmid":"32704090","id":"PMC_32704090","title":"Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32704090","citation_count":142,"is_preprint":false},{"pmid":"33845796","id":"PMC_33845796","title":"Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.","date":"2021","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33845796","citation_count":129,"is_preprint":false},{"pmid":"16449978","id":"PMC_16449978","title":"Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16449978","citation_count":122,"is_preprint":false},{"pmid":"16146777","id":"PMC_16146777","title":"Tissue transglutaminase (TG2)--a wound response enzyme.","date":"2006","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/16146777","citation_count":103,"is_preprint":false},{"pmid":"21818567","id":"PMC_21818567","title":"TG2, a novel extracellular protein with multiple functions.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21818567","citation_count":98,"is_preprint":false},{"pmid":"31570702","id":"PMC_31570702","title":"MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31570702","citation_count":97,"is_preprint":false},{"pmid":"32480093","id":"PMC_32480093","title":"Tunable bioactivity and mechanics of collagen-based tissue engineering constructs: A comparison of EDC-NHS, genipin and TG2 crosslinkers.","date":"2020","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/32480093","citation_count":94,"is_preprint":false},{"pmid":"27609180","id":"PMC_27609180","title":"IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27609180","citation_count":88,"is_preprint":false},{"pmid":"29355739","id":"PMC_29355739","title":"Nicotine induces apoptosis in human osteoblasts via a novel mechanism driven by H2O2 and entailing Glyoxalase 1-dependent MG-H1 accumulation leading to TG2-mediated NF-kB desensitization: Implication for smokers-related osteoporosis.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29355739","citation_count":85,"is_preprint":false},{"pmid":"18174247","id":"PMC_18174247","title":"The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.","date":"2008","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18174247","citation_count":82,"is_preprint":false},{"pmid":"27579892","id":"PMC_27579892","title":"PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27579892","citation_count":71,"is_preprint":false},{"pmid":"25215932","id":"PMC_25215932","title":"Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.","date":"2014","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25215932","citation_count":70,"is_preprint":false},{"pmid":"19657147","id":"PMC_19657147","title":"Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19657147","citation_count":70,"is_preprint":false},{"pmid":"20395409","id":"PMC_20395409","title":"A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors.","date":"2010","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/20395409","citation_count":67,"is_preprint":false},{"pmid":"24356421","id":"PMC_24356421","title":"GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24356421","citation_count":60,"is_preprint":false},{"pmid":"36353796","id":"PMC_36353796","title":"Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality.","date":"2022","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36353796","citation_count":59,"is_preprint":false},{"pmid":"23276939","id":"PMC_23276939","title":"TGM2 and implications for human disease: role of alternative splicing.","date":"2013","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/23276939","citation_count":59,"is_preprint":false},{"pmid":"23877317","id":"PMC_23877317","title":"TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.","date":"2013","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23877317","citation_count":56,"is_preprint":false},{"pmid":"35913916","id":"PMC_35913916","title":"SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/35913916","citation_count":55,"is_preprint":false},{"pmid":"27488529","id":"PMC_27488529","title":"TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27488529","citation_count":51,"is_preprint":false},{"pmid":"36639156","id":"PMC_36639156","title":"Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36639156","citation_count":49,"is_preprint":false},{"pmid":"28056186","id":"PMC_28056186","title":"Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network.","date":"2017","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/28056186","citation_count":48,"is_preprint":false},{"pmid":"31010374","id":"PMC_31010374","title":"TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31010374","citation_count":46,"is_preprint":false},{"pmid":"26456735","id":"PMC_26456735","title":"Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.","date":"2015","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/26456735","citation_count":46,"is_preprint":false},{"pmid":"27270573","id":"PMC_27270573","title":"Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/27270573","citation_count":45,"is_preprint":false},{"pmid":"17314516","id":"PMC_17314516","title":"GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17314516","citation_count":44,"is_preprint":false},{"pmid":"21479826","id":"PMC_21479826","title":"TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21479826","citation_count":44,"is_preprint":false},{"pmid":"16108039","id":"PMC_16108039","title":"Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.","date":"2005","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16108039","citation_count":43,"is_preprint":false},{"pmid":"23499501","id":"PMC_23499501","title":"Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.","date":"2013","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23499501","citation_count":42,"is_preprint":false},{"pmid":"23469180","id":"PMC_23469180","title":"The role of TG2 in regulating S100A4-mediated mammary tumour cell migration.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23469180","citation_count":42,"is_preprint":false},{"pmid":"26622499","id":"PMC_26622499","title":"Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.","date":"2015","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26622499","citation_count":41,"is_preprint":false},{"pmid":"29752334","id":"PMC_29752334","title":"TG2 regulates the heat-shock response by the post-translational modification of HSF1.","date":"2018","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29752334","citation_count":40,"is_preprint":false},{"pmid":"28387755","id":"PMC_28387755","title":"Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28387755","citation_count":39,"is_preprint":false},{"pmid":"18794325","id":"PMC_18794325","title":"Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.","date":"2008","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18794325","citation_count":38,"is_preprint":false},{"pmid":"22160259","id":"PMC_22160259","title":"Recent advances in the development of tissue transglutaminase (TG2) inhibitors.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22160259","citation_count":37,"is_preprint":false},{"pmid":"35679477","id":"PMC_35679477","title":"Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35679477","citation_count":36,"is_preprint":false},{"pmid":"36256821","id":"PMC_36256821","title":"TGM2-mediated histone transglutamination is dictated by steric accessibility.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36256821","citation_count":35,"is_preprint":false},{"pmid":"34902811","id":"PMC_34902811","title":"N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes.","date":"2021","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34902811","citation_count":35,"is_preprint":false},{"pmid":"33738254","id":"PMC_33738254","title":"The NEAT1_2/miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33738254","citation_count":35,"is_preprint":false},{"pmid":"17939176","id":"PMC_17939176","title":"Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17939176","citation_count":34,"is_preprint":false},{"pmid":"37441590","id":"PMC_37441590","title":"SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.","date":"2023","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/37441590","citation_count":32,"is_preprint":false},{"pmid":"28832669","id":"PMC_28832669","title":"TGC repeat expansion in the TCF4 gene increases the risk of Fuchs' endothelial corneal dystrophy in Australian cases.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28832669","citation_count":32,"is_preprint":false},{"pmid":"30015899","id":"PMC_30015899","title":"TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30015899","citation_count":31,"is_preprint":false},{"pmid":"22759359","id":"PMC_22759359","title":"Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.","date":"2012","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22759359","citation_count":29,"is_preprint":false},{"pmid":"37246171","id":"PMC_37246171","title":"Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.","date":"2023","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/37246171","citation_count":28,"is_preprint":false},{"pmid":"33435987","id":"PMC_33435987","title":"Circular RNA circ_0081001 knockdown enhances methotrexate sensitivity in osteosarcoma cells by regulating miR-494-3p/TGM2 axis.","date":"2021","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/33435987","citation_count":28,"is_preprint":false},{"pmid":"32116663","id":"PMC_32116663","title":"Role of TG2-Mediated SERCA2 Serotonylation on Hypoxic Pulmonary Vein Remodeling.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32116663","citation_count":26,"is_preprint":false},{"pmid":"31035965","id":"PMC_31035965","title":"CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31035965","citation_count":26,"is_preprint":false},{"pmid":"22652528","id":"PMC_22652528","title":"Tissue transglutaminase (TG-2) modified amniotic membrane: a novel scaffold for biomedical applications.","date":"2012","source":"Biomedical materials (Bristol, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22652528","citation_count":26,"is_preprint":false},{"pmid":"24828664","id":"PMC_24828664","title":"TGM2: a cell surface marker in esophageal adenocarcinomas.","date":"2014","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24828664","citation_count":25,"is_preprint":false},{"pmid":"27613463","id":"PMC_27613463","title":"Association of TG2 from mast cells and chronic spontaneous urticaria pathogenesis.","date":"2016","source":"Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27613463","citation_count":25,"is_preprint":false},{"pmid":"18594942","id":"PMC_18594942","title":"FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.","date":"2008","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/18594942","citation_count":22,"is_preprint":false},{"pmid":"36989728","id":"PMC_36989728","title":"TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36989728","citation_count":22,"is_preprint":false},{"pmid":"8547071","id":"PMC_8547071","title":"Band 4.2 Shiga: 317 CGC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis.","date":"1995","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/8547071","citation_count":22,"is_preprint":false},{"pmid":"23685317","id":"PMC_23685317","title":"Electrochemical magneto immunosensor for the detection of anti-TG2 antibody in celiac disease.","date":"2013","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/23685317","citation_count":22,"is_preprint":false},{"pmid":"39788430","id":"PMC_39788430","title":"TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway.","date":"2025","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/39788430","citation_count":21,"is_preprint":false},{"pmid":"34485533","id":"PMC_34485533","title":"Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling.","date":"2021","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34485533","citation_count":21,"is_preprint":false},{"pmid":"21046178","id":"PMC_21046178","title":"The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.","date":"2010","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21046178","citation_count":21,"is_preprint":false},{"pmid":"28199195","id":"PMC_28199195","title":"Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.","date":"2017","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/28199195","citation_count":20,"is_preprint":false},{"pmid":"32006666","id":"PMC_32006666","title":"Blocking TG2 attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting EMT.","date":"2020","source":"Respiratory physiology & neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32006666","citation_count":20,"is_preprint":false},{"pmid":"23824706","id":"PMC_23824706","title":"Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23824706","citation_count":20,"is_preprint":false},{"pmid":"24212645","id":"PMC_24212645","title":"Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer.","date":"2011","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/24212645","citation_count":20,"is_preprint":false},{"pmid":"18594946","id":"PMC_18594946","title":"Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells.","date":"2008","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/18594946","citation_count":18,"is_preprint":false},{"pmid":"35617996","id":"PMC_35617996","title":"Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35617996","citation_count":17,"is_preprint":false},{"pmid":"37535601","id":"PMC_37535601","title":"TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.","date":"2023","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/37535601","citation_count":17,"is_preprint":false},{"pmid":"28151477","id":"PMC_28151477","title":"Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28151477","citation_count":17,"is_preprint":false},{"pmid":"16998728","id":"PMC_16998728","title":"Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene.","date":"2006","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/16998728","citation_count":17,"is_preprint":false},{"pmid":"28952066","id":"PMC_28952066","title":"Purification and Characterization of Bacteriocin Produced by a Strain of Enterococcus faecalis TG2.","date":"2017","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28952066","citation_count":17,"is_preprint":false},{"pmid":"36041715","id":"PMC_36041715","title":"RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis.","date":"2022","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/36041715","citation_count":16,"is_preprint":false},{"pmid":"33245424","id":"PMC_33245424","title":"Enhanced neural differentiation of neural stem cells by sustained release of Shh from TG2 gene-modified EMSC co-culture in vitro.","date":"2020","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/33245424","citation_count":16,"is_preprint":false},{"pmid":"31322240","id":"PMC_31322240","title":"Overexpression of TG2 enhances the differentiation of ectomesenchymal stem cells into neuron‑like cells and promotes functional recovery in adult rats following spinal cord injury.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31322240","citation_count":16,"is_preprint":false},{"pmid":"33872388","id":"PMC_33872388","title":"High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.","date":"2021","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33872388","citation_count":15,"is_preprint":false},{"pmid":"32069794","id":"PMC_32069794","title":"Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32069794","citation_count":15,"is_preprint":false},{"pmid":"36475545","id":"PMC_36475545","title":"Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36475545","citation_count":15,"is_preprint":false},{"pmid":"39580966","id":"PMC_39580966","title":"RSL3 sensitizes glioma cells to ionizing radiation by suppressing TGM2-dependent DNA damage repair and epithelial-mesenchymal transition.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39580966","citation_count":14,"is_preprint":false},{"pmid":"35014680","id":"PMC_35014680","title":"Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling.","date":"2022","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/35014680","citation_count":14,"is_preprint":false},{"pmid":"34731200","id":"PMC_34731200","title":"TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34731200","citation_count":14,"is_preprint":false},{"pmid":"34817668","id":"PMC_34817668","title":"ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway.","date":"2021","source":"Lung","url":"https://pubmed.ncbi.nlm.nih.gov/34817668","citation_count":14,"is_preprint":false},{"pmid":"37398884","id":"PMC_37398884","title":"18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway.","date":"2023","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/37398884","citation_count":14,"is_preprint":false},{"pmid":"20112034","id":"PMC_20112034","title":"TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation.","date":"2010","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/20112034","citation_count":13,"is_preprint":false},{"pmid":"22231926","id":"PMC_22231926","title":"The role of TG2 in ECV304-related vasculogenic mimicry.","date":"2012","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22231926","citation_count":13,"is_preprint":false},{"pmid":"32441391","id":"PMC_32441391","title":"AFF1 inhibits adipogenic differentiation via targeting TGM2 transcription.","date":"2020","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/32441391","citation_count":12,"is_preprint":false},{"pmid":"31830262","id":"PMC_31830262","title":"Hyperglycemia-induced transcriptional regulation of ROCK1 and TGM2 expression is involved in small artery remodeling in obese diabetic Göttingen Minipigs.","date":"2019","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31830262","citation_count":12,"is_preprint":false},{"pmid":"18561261","id":"PMC_18561261","title":"The TGM2 gene is associated with schizophrenia in a British population.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18561261","citation_count":12,"is_preprint":false},{"pmid":"33066266","id":"PMC_33066266","title":"Vitamin D Status Modulates Inflammatory Response in HIV+ Subjects: Evidence for Involvement of Autophagy and TG2 Expression in PBMC.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33066266","citation_count":12,"is_preprint":false},{"pmid":"27864691","id":"PMC_27864691","title":"Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/27864691","citation_count":11,"is_preprint":false},{"pmid":"36872331","id":"PMC_36872331","title":"TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/36872331","citation_count":11,"is_preprint":false},{"pmid":"31786225","id":"PMC_31786225","title":"Assessment of expression and specific activities of transglutaminases TG1, TG2, and FXIII-A during osteoclastogenesis.","date":"2019","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31786225","citation_count":11,"is_preprint":false},{"pmid":"37190106","id":"PMC_37190106","title":"Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/37190106","citation_count":11,"is_preprint":false},{"pmid":"26636505","id":"PMC_26636505","title":"Mechanism of BMP and TG2 in mesenchymal stem cell osteogenesis.","date":"2015","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26636505","citation_count":11,"is_preprint":false},{"pmid":"39393274","id":"PMC_39393274","title":"Tubuloside A alleviates postmyocardial infarction cardiac fibrosis by inhibiting TGM2: Involvement of inflammation and mitochondrial pathway apoptosis.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39393274","citation_count":11,"is_preprint":false},{"pmid":"35600402","id":"PMC_35600402","title":"Multi-Omics Analysis of Glioblastoma and Glioblastoma Cell Line: Molecular Insights Into the Functional Role of GPR56 and TG2 in Mesenchymal Transition.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35600402","citation_count":11,"is_preprint":false},{"pmid":"39426226","id":"PMC_39426226","title":"Tumor-associated macrophages induce epithelial-mesenchymal transition and promote lung metastasis in breast cancer by activating the IL-6/STAT3/TGM2 axis.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39426226","citation_count":11,"is_preprint":false},{"pmid":"20003977","id":"PMC_20003977","title":"Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse.","date":"2009","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/20003977","citation_count":11,"is_preprint":false},{"pmid":"26280645","id":"PMC_26280645","title":"[TGC Repeats in Intron 2 of the TCF4 Gene have a Good Predictive Power Regarding to Fuchs Endothelial Corneal Dystrophy].","date":"2015","source":"Klinische Monatsblatter fur Augenheilkunde","url":"https://pubmed.ncbi.nlm.nih.gov/26280645","citation_count":11,"is_preprint":false},{"pmid":"27562793","id":"PMC_27562793","title":"P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/27562793","citation_count":10,"is_preprint":false},{"pmid":"34198675","id":"PMC_34198675","title":"The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34198675","citation_count":10,"is_preprint":false},{"pmid":"38085503","id":"PMC_38085503","title":"Dioscin Impedes Proliferation, Metastasis and Enhances Autophagy of Gastric Cancer Cells via Regulating the USP8/TGM2 Pathway.","date":"2023","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38085503","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54916,"output_tokens":8468,"usd":0.145884,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18098,"output_tokens":5380,"usd":0.112495,"stage2_stop_reason":"end_turn"},"total_usd":0.258379,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"GPR56 binds specifically to tissue transglutaminase TG2 in the extracellular matrix, and this interaction suppresses melanoma tumor growth and metastasis; GPR56 associates in a complex with Gαq and the tetraspanin CD81.\",\n      \"method\": \"Co-immunoprecipitation, binding assays, overexpression/knockdown experiments, xenograft tumor models\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding demonstrated, functional consequence (tumor suppression) confirmed in vivo, independently followed up by multiple subsequent studies\",\n      \"pmids\": [\"16757564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPR56 antagonizes TG2 function in melanoma by internalizing and degrading extracellular TG2, leading to decreased fibronectin deposition and impaired focal adhesion kinase accumulation; TG2 crosslinking activity promotes melanoma growth.\",\n      \"method\": \"Xenograft studies in immunodeficient Tg2-/- mice, cell-based internalization/degradation assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic model (Tg2-/- mice), mechanistic pathway (ECM deposition/FAK) established, replicates and extends earlier GPR56-TG2 finding\",\n      \"pmids\": [\"24356421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TG2 associates with β1 and β5 integrins on the surface of drug-resistant MCF-7 breast cancer cells, and this interaction strongly activates focal adhesion kinase, promoting fibronectin-mediated cell attachment and survival; siRNA knockdown of TG2 inhibits these functions.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, fibronectin attachment assays, FAK activation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP of TG2-integrin complex, functional siRNA rescue, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"16449978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Increased TG2 expression in fibroblasts activates NF-κB, resulting in upregulation of TGFβ1 expression and secretion of biologically active TGFβ1, leading to increased collagen and fibronectin synthesis and deposition; this process requires TG2 transamidase activity and can be inhibited by nitric oxide (via S-nitroso-N-acetylpenicillamine), which reduces TG2 activity and arrests the inactive enzyme on the cell surface.\",\n      \"method\": \"Tetracycline-inducible TG2 expression in Swiss 3T3 fibroblasts, site-directed TG inhibitor, NF-κB reporter assay, NO donor treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — inducible expression system with site-directed inhibitor controls, NF-κB reporter, multiple orthogonal endpoints in one study\",\n      \"pmids\": [\"19657147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TG2 transamidating activity is the primary biochemical function required for both apoptosis protection and autophagosome formation; TG2 knockout MEF cells show exacerbated caspase-3 and PARP cleavage upon apoptotic stimuli and accumulation of LC3-II upon autophagy induction, whereas reconstitution with wild-type TG2 but not the transamidation-inactive C277S mutant rescues both phenotypes.\",\n      \"method\": \"TG2 knockout MEF reconstitution with WT or C277S mutant TG2, caspase-3 activity assays, PARP cleavage, LC3-II immunoblotting\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site mutagenesis (C277S) plus knockout reconstitution with defined molecular readouts, multiple orthogonal methods\",\n      \"pmids\": [\"21479826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TG2 acting as a G protein mediates intracellular signaling via the α1b-adrenergic receptor in hepatocytes, and this signaling regulates Bcl-xL expression; TG2-/- mice show increased hepatocyte sensitivity to Fas-mediated apoptosis with decreased Bcl-xL levels, while Fas receptor levels, FLIP(L), and IκBα degradation are unchanged.\",\n      \"method\": \"TG2 knockout mice, anti-Fas antibody challenge (in vivo and in vitro), Bcl-xL/FLIP(L) immunoblotting, cell-surface Fas quantification\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic KO model with specific mechanistic readout (Bcl-xL via adrenergic signaling), multiple molecular controls in one study\",\n      \"pmids\": [\"16108039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TG2 directly interacts with S100A4 and crosslinks it (polymerizes it); S100A4 is a TG2 substrate. Inhibition of TG2 (by inhibitors or shRNA) blocks S100A4-accelerated mammary tumor cell migration. The signaling mechanism involves syndecan-4 and α5β1 integrin co-signaling linked by PKCα activation.\",\n      \"method\": \"Co-immunoprecipitation, Far Western blotting, crosslinking assays, TG2 inhibitors (cell-permeable and non-cell-permeable), shRNA knockdown, functional blocking antibodies\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro enzymatic crosslinking assay confirming substrate relationship, reciprocal co-IP, multiple inhibitor strategies with migration readout\",\n      \"pmids\": [\"23469180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKA-induced phosphorylation of TG2 at serine-216 is required for TG2-mediated activation of NF-κB, Akt phosphorylation, and downregulation of PTEN; a mutant TG2 lacking Ser216 (m-TG2) fails to activate NF-κB and Akt, and fails to suppress PTEN, indicating this PTM controls TG2's pro-survival signaling.\",\n      \"method\": \"TG2-null MEF reconstitution with WT or Ser216A mutant TG2, NF-κB reporter assay, immunoblotting, FACS, cell migration assay; confirmed in MCF-7 and T-47D breast cancer cells\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis of phosphorylation site, NF-κB reporter, replicated in two cell lines; single lab\",\n      \"pmids\": [\"22759359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TG2, dependent on its protein disulfide isomerase (PDI) activity, triggers trimerization and nuclear translocation of HSF1, activating the heat-shock response; loss of TG2 correlates with defective HSF1 nuclear translocation and reduced binding to the HSP70 promoter. TG2 absence impairs the HSF1-HSP70 pathway in cystic fibrosis cells and increases CFTR function by ~40% in TG2-/- CF mouse models.\",\n      \"method\": \"TG2 knockout mice (CF model), TG2 loss-of-function in cells, HSF1 DNA-binding/promoter assay, nuclear translocation imaging, CFTR functional measurement\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo KO model, multiple orthogonal methods (nuclear translocation, DNA binding, functional CFTR assay), mechanistic activity (PDI) identified\",\n      \"pmids\": [\"29752334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TGM2-mediated histone serotonylation (monoaminylation of H3Q5) is excluded from constitutive heterochromatic regions because higher-order chromatin structure imposes a steric barrier; nucleosome-level studies show steric hindrance restricts TGM2 activity to accessible histone tail sites, with substrate accessibility—not primary sequence or pre-existing PTMs—being the primary determinant of TGM2-mediated histone monoaminylation.\",\n      \"method\": \"Biochemical histone serotonylation assays with chromatin substrates, DNA-barcoded nucleosome libraries, structure-activity relationship studies, mammalian cell chromatin mapping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with nucleosome libraries, multiple orthogonal biochemical and cell-based approaches, mechanistic principle established\",\n      \"pmids\": [\"36256821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TGM2 promotes formation of mitochondria-associated ER membranes (MAMs) and facilitates IP3R1–VDAC1 interactions, resulting in mitochondrial calcium influx and mtROS accumulation; TGM2 silencing inhibits IP3R1–VDAC1 tethering and prevents high glucose-induced mitochondrial calcium overload.\",\n      \"method\": \"TGM2 siRNA knockdown, co-immunoprecipitation of IP3R1-VDAC1, mitochondrial calcium measurement (Fluo-4AM), mtROS assay, STZ-induced diabetic mouse model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP demonstrating tethering complex, siRNA loss-of-function with calcium/ROS readouts, in vivo STZ model; single lab\",\n      \"pmids\": [\"32704090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"After irradiation, TGM2 binds SDC1 and is transported from the cell membrane to lysosomes; TGM2 then binds LC3 through two LC3-interacting regions (LIRs), coordinating autophagosome-lysosome fusion by enabling lysosomal EPG5 to recognize LC3 and stabilize the STX17-SNAP29-VAMP8 SNARE complex assembly, thereby promoting radioresistance in glioblastoma.\",\n      \"method\": \"Co-immunoprecipitation, confocal imaging of autophagosome-lysosome fusion, mRFP-GFP-LC3 reporter, LIR mutation analysis, TGM2 inhibitor (cystamine) in orthotopic GBM mice\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP defining multi-protein complex, LIR-LC3 interaction, mechanistic pathway through SNARE complex, in vivo model with survival endpoint\",\n      \"pmids\": [\"35913916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"After irradiation, SDC1 carries TGM2 from the cell membrane into cytoplasm and transports it to lysosomes via flotillin 1 (FLOT1); TGM2 then recognizes BHMT on autophagosomes to coordinate autophagosome-lysosome encounter, forming the SDC1-TGM2-FLOT1-BHMT complex that maintains autophagic flux and enhances GBM radioresistance.\",\n      \"method\": \"Co-immunoprecipitation, TMT quantitative proteomics, immunofluorescence, mRFP-GFP-LC3, transmission electron microscopy, colony formation assays\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP defining four-protein complex, multiple imaging methods; single lab, partially overlapping with prior study (PMID 35913916)\",\n      \"pmids\": [\"37441590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cytosolic TGM2 suppresses TRIM21-mediated ubiquitination and degradation of STAT1 by facilitating dissociation of the TRIM21–STAT1 complex; this requires TGM2's GTP-binding enzymatic activity (not transamidase activity), stabilizing STAT1 and promoting gastric cancer progression. TRIM21 is identified as the E3 ubiquitin ligase for STAT1 in gastric cancer.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, TGM2 GTP-binding mutants, calcium ionophore (A23187) to abolish GTP-binding activity, ubiquitination assays, xenograft models\",\n      \"journal\": \"Cancer communications (London, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — MS-identified interactors, enzymatic activity mutants distinguishing GTP-binding vs transamidase, ubiquitination assay, in vivo rescue; single lab\",\n      \"pmids\": [\"36353796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TG2 forms complexes with NF-κB components and induces IL-6 production, which in turn triggers enhanced autophagy in drug-resistant mantle cell lymphoma cells through STAT3 signaling; ATG5 positively feeds back to regulate TG2/NF-κB/IL-6 signaling, constituting a positive feedback loop for MCL cell survival.\",\n      \"method\": \"CRISPR-mediated TG2 silencing, TG2 overexpression, co-immunoprecipitation with NF-κB components, autophagy assays, IL-6 measurements, xenograft models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO, co-IP, multiple functional readouts; single lab\",\n      \"pmids\": [\"27488529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Active TG2 directly interacts with β3 integrins (demonstrated by co-immunoprecipitation), acting as a co-receptor for fibronectin; active TG2 (but not the C277S transamidation-inactive mutant) increases TGFβ1 levels and matrix-deposited fibronectin in CT26 colon carcinoma cells, increasing cell adhesion and reducing migration/invasion.\",\n      \"method\": \"Stable transfection of WT vs. C277S TG2 mutant in CT26 cells, immunoprecipitation of TG2-β3 integrin complex, TG2 site-directed inhibitors, TGFβ1 ELISA, fibronectin deposition assays\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus active-site mutant comparison, multiple functional readouts; single lab\",\n      \"pmids\": [\"21046178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Inhibition of TG2 transamidase activity with a cell-permeable fluorescent peptidomimetic inhibitor blocks TG2 binding to cell surface syndecan-4, inhibits translocation of TG2 into the ECM, and reduces fibronectin deposition, cell motility, and cord formation; in a mouse model of hypertensive nephrosclerosis, TG2 inhibition reduced collagen deposition by >40%.\",\n      \"method\": \"Fluorescently labeled cell-permeable TG2 inhibitor, live-cell imaging, fibronectin deposition assays, Matrigel cord assay, hypertensive nephrosclerosis mouse model\",\n      \"journal\": \"Chemistry & biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific inhibitor with multiple orthogonal cellular and in vivo readouts; single lab\",\n      \"pmids\": [\"26456735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Missense mutations in TGM2 located near the catalytic site (N333S, M330R, I331N) impair transamidating activity in vitro; TG2 is the only transglutaminase significantly expressed in human pancreatic islet cells, and Tgm2-/- mice are glucose-intolerant with impaired insulin secretion.\",\n      \"method\": \"In vitro transamidation activity assay of mutant TG2 proteins, gene expression analysis in human pancreas, Tgm2 knockout mouse phenotyping (glucose tolerance test)\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro enzymatic assay of patient-derived mutants, KO mouse phenotype; single lab\",\n      \"pmids\": [\"17939176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hypoxia enhances TG2 expression and activity in pulmonary vein smooth muscle cells (hPVSMC) in a HIF-2-dependent manner; TG2 mediates serotonylation (covalent serotonin modification) of SERCA2, inhibiting SERCA2 activity and increasing cytosolic calcium via TRPC6-mediated calcium influx; vascular smooth muscle-specific Tgm2-/- mice are protected from hypoxia-induced pulmonary hypertension.\",\n      \"method\": \"Co-immunoprecipitation of TG2 and SERCA2, TG2 gene silencing/overexpression, calcium imaging (Fluo-4AM), smooth muscle-specific TG2 knockout mice, hypoxic pulmonary hypertension model (RVSP, RVHI measurements)\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro enzymatic serotonylation assay (co-IP), tissue-specific KO mouse with disease phenotype, multiple mechanistic readouts\",\n      \"pmids\": [\"32116663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Lung-resident neutrophils express TGM2, which is induced by PGE2 via protein kinase A (PKA) signaling; TGM2 mediates the immune-suppressive phenotype of lung neutrophils, and Tgm2-/- mice release high levels of inflammatory cytokines and show exacerbated lung damage in LPS-induced acute respiratory distress syndrome.\",\n      \"method\": \"Tgm2-/- mice, LPS-induced ARDS model, bronchoalveolar lavage fluid treatment of bone marrow neutrophils, PGE2/PKA pathway pharmacological dissection\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO model with defined disease phenotype and pathway (PGE2/PKA/TGM2) established; single lab\",\n      \"pmids\": [\"35679477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TG2 overexpression in neuroblastoma SH-SY5Y cells protects against etoposide-induced cell death; this protection requires transamidase activity since the C277S inactive mutant fails to suppress caspase-3 activation and p53 phosphorylation.\",\n      \"method\": \"Overexpression of WT vs. C277S TG2 mutant, antisense TG2 knockdown, caspase-3 activity assay, p53 phosphorylation immunoblotting\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — active-site mutagenesis distinguishing transamidase activity, loss-of-function antisense construct, defined molecular readouts; single lab\",\n      \"pmids\": [\"20112034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PARP3 promotes TGFβ-induced EMT by stimulating a TG2-Snail-E-cadherin axis; PARP3 depletion prevents TGFβ-dependent induction of TG2 and Snail expression, dissolution of cell junctions, and acquisition of cell motility.\",\n      \"method\": \"PARP3 siRNA depletion, TGFβ stimulation, immunoblotting for TG2/Snail/E-cadherin, cell motility assays, mammary epithelial and breast cancer cell models\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA depletion with defined axis (TG2-Snail-E-cadherin), multiple cell types tested; single lab, no direct TG2-PARP3 binding shown\",\n      \"pmids\": [\"27579892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Weakly migratory metastatic breast cancer cells release microvesicles rich in TG2, which activate murine fibroblasts and lead weakly migratory cancer cell migration in vitro; these microvesicles induce tumor stiffening and fibroblast activation in vivo and enhance metastasis of weakly migratory cells.\",\n      \"method\": \"Microvesicle isolation, TG2 content analysis, fibroblast activation assays, in vitro migration, in vivo tumor stiffness and metastasis models\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — TG2 identified as active cargo in microvesicles, in vitro and in vivo functional validation; single lab\",\n      \"pmids\": [\"36475545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Fyn tyrosine kinase phosphorylates TGM2 on tyrosine-369 (Y369); Fyn-dependent phosphorylation of TGM2 regulates autophagy in proximal renal tubules, and TGM2 knockdown decreases p53 expression in autophagic conditions, identifying a Fyn-TGM2-p53 axis in diabetic kidney disease.\",\n      \"method\": \"Phospho-proteomic analysis, in vitro kinase assay, TGM2 knockdown in proximal tubule cells, STZ-induced hyperglycemic mouse model, immunoblotting\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — phospho-proteomics identifying Y369 site, in vitro and in vivo validation; single lab\",\n      \"pmids\": [\"37190106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TGM2 catalyzes H3Q5 serotonylation (H3Q5ser) in hepatocellular carcinoma; transcriptional intermediary factor 1β (TIF1β) mediates recruitment of TGM2 to MYC target gene loci, facilitating H3Q5ser modifications that promote MYC pathway gene expression and HCC progression.\",\n      \"method\": \"CUT&Tag (chromatin profiling), RNA sequencing, adeno-associated virus liver-specific TGM2/H3.3 overexpression, HCC organoids, xenograft and hydrodynamic tail vein injection models, TGM2 inhibitor treatment\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — CUT&Tag chromatin mapping, multiple in vivo models, specific enzymatic activity (transglutaminase) validated, TIF1β-TGM2 recruitment mechanism identified\",\n      \"pmids\": [\"39788430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In microglia, TGM2's proinflammatory effects are dependent on its GTP-binding activity rather than transamidase activity; TGM2 activates the NF-κB signaling pathway to facilitate microglial activation, and propofol inhibits microglial inflammation by suppressing TGM2 expression and downstream NF-κB signaling.\",\n      \"method\": \"TGM2 siRNA knockdown, gain-of-function overexpression with GTP-binding vs. transamidase activity mutants, NF-κB signaling assays, BV2 cells and primary microglia\",\n      \"journal\": \"Journal of immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — activity-specific mutants distinguishing GTP-binding from transamidase function, loss- and gain-of-function in two cell types; single lab\",\n      \"pmids\": [\"34485533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RSL3-induced oxidative stress promotes S-glutathionylation of TGM2 via upregulation of GSTP1, leading to proteasomal degradation of TGM2; this suppresses nuclear accumulation of TGM2 and disrupts TGM2–topoisomerase IIα interaction after irradiation, impairing DNA DSB repair and sensitizing glioma cells to radiation.\",\n      \"method\": \"TGM2 overexpression/knockdown, co-immunoprecipitation of TGM2-topoisomerase IIα, S-glutathionylation detection, γH2AX DSB assay, GSTP1 manipulation, U87 xenograft model\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP identifying TGM2-topoisomerase IIα interaction, PTM (S-glutathionylation) identified with functional consequence, in vivo xenograft; single lab\",\n      \"pmids\": [\"39580966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TG2 inhibition (by site-directed irreversible inhibitors or antisense transfection) blocks tubular structure formation in a vasculogenic mimicry model; TG2 in situ activity co-localizes with fibronectin and collagen IV in tube structures, and non-cell-permeable TG inhibitors reduce ECM deposition, indicating TG2's contribution to tube formation is extracellular.\",\n      \"method\": \"TG2 antisense transfection, cell-permeable and non-cell-permeable TG2 site-directed inhibitors, in situ TG activity assay, co-localization with fibronectin/collagen IV, tube formation assay\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-permeable vs non-cell-permeable inhibitor strategy distinguishes intracellular vs extracellular TG2 activity, antisense KD; single lab\",\n      \"pmids\": [\"22231926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TG2 and FXIII-A control monocyte-macrophage differentiation into osteoclasts and regulate RANKL production in mesenchymal stem cells and adipocytes; TG2/FXIII-A-deficient mice show increased osteoclastogenesis and trabecular bone loss, while TG2/FXIII-A-null MSCs show defective plasma fibronectin assembly.\",\n      \"method\": \"TG2 and FXIII-A double-knockout mice, in vitro osteoclastogenesis assays, chemical TG activity inhibition, bone histomorphometry, FN assembly assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO model with bone phenotype, in vitro cellular differentiation assays, chemical inhibitor to distinguish TG isoforms; single lab\",\n      \"pmids\": [\"28387755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AFF1 binds directly to the promoter region of the Tgm2 gene and regulates its transcription; AFF1 depletion enhances adipogenic differentiation of hMSCs, and overexpression of TGM2 largely rescues adipogenic differentiation in AFF1-deficient cells, placing TGM2 downstream of AFF1 in adipogenesis.\",\n      \"method\": \"ChIP-qPCR demonstrating AFF1 binding to TGM2 promoter, AFF1 siRNA and overexpression, TGM2 overexpression rescue, oil red O staining, in vivo adipose formation assay\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-qPCR directly demonstrating promoter binding, rescue experiment with TGM2 overexpression; single lab\",\n      \"pmids\": [\"32441391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TG2 activity is increased in mast cells activated via IgE; serum TG2 activity is elevated in CSU patients and positively correlates with inflammatory mediator levels (histamine, LTC4, TNF-α, TGF-β, IL-4, IL-5, IL-6), and TG2 co-localizes with the mast cell marker c-kit in CSU lesional skin.\",\n      \"method\": \"Serum TG2 ELISA activity assay, IgE-activated CBMC and PBMC-derived mast cells, immunofluorescence co-localization in skin biopsies\",\n      \"journal\": \"Annals of allergy, asthma & immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative serum activity data plus single immunofluorescence co-localization; no direct mechanistic link established\",\n      \"pmids\": [\"27613463\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TGM2 (tissue transglutaminase 2) is a multifunctional Ca²⁺-dependent enzyme with transamidase (protein crosslinking), GTPase/G-protein signaling, protein disulfide isomerase, and kinase activities; its transamidase activity crosslinks ECM proteins (fibronectin, collagen), serotonylates substrates (SERCA2, histone H3Q5), and regulates apoptosis and autophagy, while its GTP-binding activity mediates adrenergic receptor signaling, NF-κB activation, and STAT1 stabilization; at the cell surface it forms co-receptor complexes with β1/β3/β5 integrins and syndecan-4 to activate FAK and PKCα-mediated adhesion/survival signaling, is regulated by phosphorylation (Ser216 by PKA; Tyr369 by Fyn) and S-glutathionylation, and is inhibited extracellularly by GPR56-mediated internalization and degradation; within the nucleus TGM2 installs H3Q5 serotonylation at MYC target genes via TIF1β recruitment to promote transcription, and its PDI activity activates HSF1 trimerization to drive the heat-shock response.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TGM2 is a multifunctional enzyme whose distinct biochemical activities—Ca²⁺-dependent transamidation, GTP-binding, and protein disulfide isomerase (PDI) activity—drive context-specific control of extracellular matrix assembly, cell survival, autophagy, and transcription [#4, #8, #13]. Its transamidase activity, dependent on the active-site cysteine (mutated in C277S), is the primary function required for protection from apoptosis and for autophagosome formation, crosslinks matrix proteins, and polymerizes substrates such as S100A4 to promote tumor cell migration [#4, #6, #20]. At the cell surface TGM2 acts as a fibronectin co-receptor in complexes with β1/β3/β5 integrins and syndecan-4, activating focal adhesion kinase and PKCα to drive fibronectin-mediated adhesion and survival signaling [#2, #6, #15], and it promotes a feed-forward fibrotic program by activating NF-κB to upregulate TGFβ1 and increase collagen/fibronectin deposition [#3, #16]. Through monoaminylation chemistry TGM2 serotonylates SERCA2 to inhibit calcium reuptake in hypoxic pulmonary smooth muscle and installs H3Q5 serotonylation on chromatin, with substrate accessibility rather than sequence determining nucleosomal targeting, and TIF1β recruiting TGM2 to MYC target loci to activate transcription [#9, #18, #24]. Independently of transamidation, TGM2's GTP-binding activity activates NF-κB and stabilizes STAT1 by displacing it from the TRIM21 E3 ligase, while its PDI activity triggers HSF1 trimerization and the heat-shock response [#8, #13, #25]. TGM2 activity and localization are tuned by post-translational modifications—PKA phosphorylation at Ser216 enables NF-κB/Akt pro-survival signaling, Fyn phosphorylation at Tyr369 regulates autophagy, and S-glutathionylation triggers its degradation [#7, #23, #26]. Genetically, TGM2 catalytic-site missense mutations impair transamidation and Tgm2-deficient mice are glucose-intolerant with impaired insulin secretion, linking the enzyme to islet function [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that TGM2 functions as a G protein in receptor signaling distinct from its crosslinking role, controlling apoptotic threshold via Bcl-xL.\",\n      \"evidence\": \"Tgm2 knockout mice challenged with anti-Fas, with Bcl-xL/FLIP immunoblotting and α1b-adrenergic receptor analysis in hepatocytes\",\n      \"pmids\": [\"16108039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which TGM2 enzymatic activity (GTP-binding vs transamidase) mediates the adrenergic signaling\", \"Mechanism of Bcl-xL transcriptional control left undefined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined TGM2's cell-surface role as an integrin co-receptor that activates FAK to drive fibronectin adhesion and survival, and identified GPR56 as a binding partner that suppresses tumor growth.\",\n      \"evidence\": \"Co-IP of TG2–integrin and TG2–GPR56 complexes, siRNA knockdown, fibronectin attachment/FAK assays, xenograft models\",\n      \"pmids\": [\"16449978\", \"16757564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether integrin binding requires catalytic activity not addressed\", \"Structural basis of TG2–GPR56 interaction unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed that TGM2 transamidase activity drives a profibrotic program by activating NF-κB and inducing TGFβ1, connecting the enzyme to matrix synthesis.\",\n      \"evidence\": \"Tetracycline-inducible TG2 in fibroblasts, site-directed TG inhibitor, NF-κB reporter, NO donor treatment\",\n      \"pmids\": [\"19657147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct crosslinking substrate triggering NF-κB not identified\", \"How NO arrests enzyme on cell surface mechanistically unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Used active-site mutants to prove transamidase activity is required for TGM2's anti-apoptotic function and to confirm β3-integrin co-receptor activity raises matrix fibronectin.\",\n      \"evidence\": \"WT vs C277S TG2 in neuroblastoma and colon carcinoma cells, caspase-3/p53 assays, TG2–β3 co-IP, fibronectin deposition\",\n      \"pmids\": [\"20112034\", \"21046178\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Survival substrate of transamidation not identified\", \"Single-lab findings for each cell context\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Pinpointed transamidation as the single activity required for both apoptosis protection and autophagosome formation using knockout reconstitution.\",\n      \"evidence\": \"TG2-null MEF reconstituted with WT or C277S, caspase-3/PARP cleavage and LC3-II immunoblotting\",\n      \"pmids\": [\"21479826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular crosslinking targets governing autophagy unresolved\", \"Subcellular site of relevant activity not localized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified PKA-mediated Ser216 phosphorylation as a switch enabling TGM2's pro-survival NF-κB/Akt/PTEN signaling.\",\n      \"evidence\": \"TG2-null MEF reconstituted with WT or Ser216A mutant, NF-κB reporter, immunoblotting, validated in two breast cancer lines\",\n      \"pmids\": [\"22759359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Ser216 phosphorylation alters enzymatic activity unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established that TGM2 polymerizes S100A4 to promote migration, that the GPR56 antagonism proceeds via TG2 internalization/degradation, and that extracellular TG2 activity supports vasculogenic tube formation.\",\n      \"evidence\": \"Crosslinking/Far-Western/co-IP for S100A4, Tg2-/- xenografts for GPR56, cell-permeable vs non-permeable inhibitors for tube formation\",\n      \"pmids\": [\"23469180\", \"24356421\", \"22231926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Syndecan-4/PKCα signaling steps downstream of S100A4 incompletely mapped\", \"Identity of physiological extracellular substrates in tubes partial\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Distinguished GTP-binding from transamidase activity in inflammatory signaling and embedded TGM2 in NF-κB/IL-6/autophagy survival loops and TGFβ-driven EMT axes.\",\n      \"evidence\": \"Activity-specific mutants in microglia, CRISPR silencing/co-IP with NF-κB in lymphoma, PARP3 depletion in EMT models, syndecan-4-targeted inhibitor\",\n      \"pmids\": [\"34485533\", \"27488529\", \"27579892\", \"26456735\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TG2–PARP3 binding not shown\", \"GTP-binding effector linking to NF-κB not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Assigned a PDI-dependent function to TGM2 in triggering HSF1 trimerization and the heat-shock response, with disease relevance in cystic fibrosis.\",\n      \"evidence\": \"TG2 knockout CF mice, HSF1 nuclear translocation/DNA-binding assays, CFTR functional measurement\",\n      \"pmids\": [\"29752334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct disulfide substrate on HSF1 not identified\", \"How PDI activity is regulated in cells unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined serotonylation as a TGM2 catalytic output controlling calcium handling, modifying SERCA2 in hypoxic pulmonary smooth muscle and tethering ER–mitochondria membranes for calcium influx.\",\n      \"evidence\": \"TG2–SERCA2 and IP3R1–VDAC1 co-IPs, calcium/mtROS imaging, smooth-muscle-specific Tgm2-/- and STZ diabetic mouse models\",\n      \"pmids\": [\"32116663\", \"32704090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MAM tethering involves crosslinking of specific substrates unresolved\", \"HIF-2 to TG2 transcriptional link mechanism partial\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed TGM2 GTP-binding stabilizes STAT1 by displacing TRIM21, defined SDC1-dependent lysosomal trafficking that couples TGM2 to autophagosome–lysosome fusion, and showed chromatin accessibility governs histone serotonylation.\",\n      \"evidence\": \"GTP-binding mutants/ubiquitination assays for STAT1, LIR-mutation and SNARE-complex analysis for SDC1-TGM2-LC3, DNA-barcoded nucleosome libraries for H3Q5ser, microvesicle TG2 cargo assays\",\n      \"pmids\": [\"36353796\", \"35913916\", \"36256821\", \"35679477\", \"36475545\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GTP-binding promotes TRIM21–STAT1 dissociation structurally unknown\", \"Signal triggering SDC1-mediated TGM2 internalization beyond irradiation unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mapped Fyn phosphorylation of TGM2 at Tyr369 regulating renal autophagy and extended the SDC1 trafficking complex to FLOT1 and BHMT for radioresistance.\",\n      \"evidence\": \"Phospho-proteomics/in vitro kinase assay for Y369, TMT proteomics and co-IP for SDC1-TGM2-FLOT1-BHMT complex, STZ and GBM models\",\n      \"pmids\": [\"37190106\", \"37441590\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of Y369 phosphorylation on enzymatic activity not defined\", \"Partly overlapping single-lab GBM studies\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed S-glutathionylation, driven by GSTP1 under oxidative stress, degrades TGM2 and disrupts its nuclear topoisomerase IIα interaction, controlling DNA double-strand break repair.\",\n      \"evidence\": \"Co-IP of TGM2–topoisomerase IIα, S-glutathionylation detection, γH2AX assays, GSTP1 manipulation, U87 xenografts\",\n      \"pmids\": [\"39580966\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TGM2 enzymatically modifies topoisomerase IIα unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established TGM2 as a chromatin-modifying enzyme recruited by TIF1β to MYC target loci to install H3Q5 serotonylation and activate oncogenic transcription.\",\n      \"evidence\": \"CUT&Tag, RNA-seq, AAV liver-specific overexpression, HCC organoids and in vivo models, TGM2 inhibitor\",\n      \"pmids\": [\"39788430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TIF1β selects specific MYC loci unresolved\", \"Reader proteins for H3Q5ser not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TGM2's multiple activities (transamidase, GTP-binding, PDI) are coordinately switched within a single cell, and the rules governing its localization between surface, cytosol, mitochondria-associated membranes, and nucleus, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified structural model linking PTM state to activity selection\", \"Trafficking determinants between compartments incompletely defined\", \"Physiological serotonylation substrate repertoire largely uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4, 6, 18, 24]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [13, 25]},\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [4, 6, 24]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [9, 24]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [2, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 1, 3, 27]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 11, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [24, 26]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [11, 12]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [3, 15, 27]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [4, 11, 12, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 5, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 25]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [24, 9]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [\n      \"TGM2-integrin co-receptor complex\",\n      \"SDC1-TGM2-FLOT1-BHMT complex\",\n      \"GPR56-Gαq-CD81 complex\"\n    ],\n    \"partners\": [\n      \"ITGB3\",\n      \"ITGB1\",\n      \"SDC4\",\n      \"SDC1\",\n      \"GPR56\",\n      \"S100A4\",\n      \"STAT1\",\n      \"MAP1LC3B\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}